Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-31

Clinical Trial Update: Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide and paclitaxel with or without trastuzumab in surgically treated stage I-II breast cancer; trial completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • PACLITAXEL (PACLITAXEL)
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Nebraska | Conditions: Stage IA Breast Cancer, Stage IB Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-31